Pages that link to "Q33465433"

The following pages link to Doxycycline-mediated inhibition of choroidal neovascularization (Q33465433):

Displaying 19 items.

• Ocular drug delivery (Q30475605) (← links)
• Doxycycline's effect on ocular angiogenesis: an in vivo analysis. (Q33626160) (← links)
• The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization (Q33677016) (← links)
• Ocular penetration of topically applied 1% tigecycline in a rabbit model. (Q33706051) (← links)
• A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration. (Q33811616) (← links)
• Systemic low-molecular weight drug delivery to pre-selected neuronal regions (Q33837170) (← links)
• IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn (Q34064081) (← links)
• Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms (Q34277464) (← links)
• Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularization (Q35087983) (← links)
• Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease (Q35907009) (← links)
• Differential Effects of Dexamethasone and Doxycycline on Inflammation and MMP Production in Murine Alkali-Burned Corneas Associated with Dry Eye. (Q36829083) (← links)
• The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential (Q37000498) (← links)
• Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9. (Q37242419) (← links)
• Anti-inflammatory and Anti-apoptotic Effect of Valproic Acid and Doxycycline Independent from MMP Inhibition in Early Radiation Damage (Q41383708) (← links)
• All vessels are not created equal (Q47179466) (← links)
• Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration (Q48524275) (← links)
• Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage (Q58799509) (← links)
• Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations (Q90433260) (← links)
• Macrophage immunomodulation in chronic osteolytic diseases-the case of periodontitis (Q93212209) (← links)